stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test.

stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test.

August 2021

Source: Aliment Pharmacol Ther. 2021;53:939–940.

Publication: